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ABSTRACT
The three-dimensional (3D) structures of many
biomacromolecules have been solved to reveal the
functions of these molecules. However, these 3D
structures have rarely been applied to constructing
efficient molecular devices that function in living
cells. Here, we demonstrate a 3D structure-based
molecular design principle for constructing short
hairpin RNA (shRNA)-mediated genetic information
converters; these converters respond to specific
proteins and trigger the desired gene expression
by modulating the function of the RNA-processing
enzyme Dicer. The inhibitory effect on Dicer
cleavage against the shRNA designed to specifically
bind to U1A spliceosomal protein was correlated
with the degree of steric hindrance between Dicer
and the shRNA-protein complex in vitro: The level of
the hindrance was predicted based on the models.
Moreover, the regulation of gene expression was
achieved by using the shRNA converters designed
to bind to the target U1A or nuclear factor-iB
(NF-iB) p50 proteins expressed in human cells.
The 3D molecular design approach is widely applic-
able for developing new devices in synthetic
biology.
INTRODUCTION
Artiﬁcial signal-converting systems have the potential to
respond to intracellular biomacromolecules (e.g. speciﬁc
proteins) and can control and rewire gene networks in
living cells (1–4). These systems could be useful devices in
biological science, medical science and engineering. Gener-
ally, synthetic molecular devices have been designed by
connecting naturally occurring modular parts [e.g. deoxy-
ribonucleic acid (DNA), ribonucleic acid (RNA) and
amino acid sequences] (5,6). Thus far, the method for
constructing these devices depends on the primary and
secondary structures of the biomolecules, without account-
ing for their three-dimensional (3D) structures. For
example, several synthetic RNA devices that control gene
expression through the interaction between RNA and its
ligands (e.g. antibiotics or proteins) have been designed
and constructed (1,2,7–10). Speciﬁc target-sensing sites
(e.g. naturally occurring RNA motifs or in vitro selected
RNA aptamers) were inserted into RNA sequences based
on the free energies of the RNA secondary structures
(11–13). However, the capabilities of such devices are dif-
ﬁcult to predict in most cases. Another approach has been
to use experimental evolution techniques to generate the
functions of the RNA devices (14,15). These techniques
are labor intensive in general, and it is impossible to
predict whether the desired sequences are present in an
RNA pool consisting of random sequences before evolu-
tion. Consequently, it has been impossible to predict or
optimize the performance of the devices without perform-
ing a functional screen (14,15).
As a new approach to constructing predictable and
functional devices, 3D molecular design incorporating
tertiary interactions between the biomacromolecular
components of the device now seems to be feasible
because of the increasing number of molecular com-
plexes in the 3D structure-based library. 3D design of
biomacromolecular complexes is likely to serve as an
advanced method for producing next generation devices
in synthetic and chemical biology because the perform-
ance of such devices is highly predictable. However, a
rational 3D design has not yet been implemented for con-
structing useful biomacromolecular complexes [e.g. RNA–
protein complexes (RNP)] that function in living cells
(11,16,17).
Naturally occurring RNA-mediated signal converters
have been discovered in human systems (18–21). For
example, the Lin28 protein interacts with pre-let-7
microRNA (miRNA) and blocks the processing of
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pre-let-7miRNA into mature let-7 miRNA, which leads to
the derepression of let-7 target genes, including oncogenes
and cell cycle genes. Crystal and nuclear magnetic reson-
ance structural analyses have shown that the cooperative
interactions of two distinct regions in the lin28-let-7
complex are critical for inhibiting the activity of the
RNA-processing enzyme Dicer (22). Accordingly, by
mimicking the function of natural RNAs, we sought to con-
struct a synthetic short hairpin RNA (shRNA) that
responds to a protein of interest and activates target gene
expression.
Here, we report the 3D structure-based molecular design
and construction of RNA-mediated protein information
converters. The RNA device is designed to interact with
a target protein that is expressed in cells and trigger the
desired gene expression. We designed protein-responsive
shRNAs in silico on the basis of high-resolution structures
of known RNP complexes and evaluated their perform-
ance in mammalian cells. The designed shRNA senses
the target proteins and inhibits the activity of Dicer,
thereby controlling the RNA interference (RNAi)
pathway in a predictable manner.
MATERIALS AND METHODS
3D modeling of protein responsive shRNAs and their
trigger proteins
The 3D atomic model of the N-terminal domain of U1A
(human) and its binding motif in U1snRNA (U1A1 motif)
or in the 30-untranslated region of U1A messenger
RNA (mRNA; U1A2 motif) were obtained from Protein
Data Bank (PDB) (ID: 1URN and ID: 1AUD, respect-
ively). The 3D atomic model of p50 [mouse nuclear
factor-kB (NF-kB)] bound to its aptamer RNA was
obtained from PDB (ID: 1OOA). The 3D model of
human NF-kB p50 and its aptamer has yet to be
determined; therefore, we used the model of mouse
NF-kB p50 for our 3D design. Beforehand, we veriﬁed
the amino acid sequence differences between mouse and
human p50 and conﬁrmed that the six point mutations
between the two were on either the terminal region or the
loop far from the RNA-binding domain; therefore, the mu-
tations are likely not critical for the structure and binding
afﬁnity. Molecular designs were performed with Discovery
Studio (Accelrys) as previously described (23). Parts of the
protein sequences were trimmed in silico to correspond to
the regions of p50 and U1A-expressing proteins. The RNA
stem region of the p50 aptamer and U1A-binding motifs
were connected to double-stranded RNA (dsRNA) by
using the superimpose protocol. The corresponding
atomic coordinates of sugar, base and phosphate backbone
in the four terminal bp of dsRNA and the protein-binding
RNA motif were tethered, and the distance between these
tethered coordinates was minimized using least squares ap-
proximation polynomial.
shRNA transcription in vitro
For in vitro shRNA transcription, a single-stranded tem-
plate was annealed to the T7 annealing primer 50-GCTAA
TACGACTCACTATA-30. shRNAs were transcribed and
puriﬁed as follows: the transcription reaction mixtures
were incubated for 3–4 h at 37C. Then, the template
DNA was degraded for 20min at 37C with 10 ml of
TURBO DNase (Ambion). Any proteins in the mixture
were removed by phenol–chloroform extraction, and nu-
cleotide monomers were removed by PD-10 column puri-
ﬁcation (GE Healthcare) and ethanol precipitation. The
shRNAs were puriﬁed using 15% native polyacrylamide
gel electrophoresis and eluted with 500ml of elution buffer
(0.5M NaCl, 0.1% sodium dodecyl sulphate and 1mM
EDTA) at 37C overnight. The eluted shRNAs were
ﬁltered with a 22-mm microﬁlter (Millex GP) and
precipitated with ethanol. The DNA templates used in
this study are described in Supplementary Table S2.
Inhibition assay of human Dicer cleavage
for shRNA in vitro
In vitro-transcribed U1A protein-responsive shRNA
device variants (U1A1- or dU1A1- sh 21–31; 0.5 mM) and
recombinant U1A protein (0 or 5 mM) were mixed with
1 ml of 10mM adenosine triphosphate (ATP), 0.5 ml of
50mM MgCl2, 4 ml of Dicer Reaction Buffer (Genlantis),
1 ml of 0.5 unit/ml Recombinant Human Dicer Enzyme
(Genlantis) and water (up to 10 ml). The mixtures were
incubated at 37C for 15 h, and the incubation was
stopped using 1 ml of Dicer stop solution. The mixtures
were separated by 15% native polyacrylamide gel electro-
phoresis at 4C for 30min, and the gel was stained with
SYBER-Green I and II (Takara Bio Inc). The ﬂuorescence
of the stained RNA was detected by FLA-7000 (Fujiﬁlm).
The assays using other samples were conducted using the
above mentioned procedure.
Construction of NF-iB (p50), U1A or MS2 coat protein
expression plasmids
The NF-kB p50 (amino acids 39–352 of human NF-kB1)
gene was ampliﬁed by polymerase chain reaction from
total complementary DNA (cDNA) from HeLa cells,
using the following primers: NF-kB (p50) Fwd (50-CCA
GGATCCCACCATGGATGGCCCATACCTTCAAAT
ATTAGAGC-30) and NF-kB (p50) Rev (50-tcgCTCGAG
TTCAGGATAGTAGAGGAAAGGTTTTGG-30). The
gene was then cloned into pcDNA3.1-mycHisA
(pcDNA, Invitrogen) between the BamHI and XhoI
sites to construct the p50 expression plasmid, and the
sequence was veriﬁed.
The sequence coding U1A (amino acids 2–98 of human
U1A, without nuclear localization signal) or MS2 (bac-
teriophage MS2 coat protein with amino acids 68–81
deleted) was ampliﬁed using the following primers:
U1A_T Fwd (50-GACACCATGGGATCCGCAGTTCC
CGAGA -30)/U1A_T Rev (50-TATGAGATCTTTTCAT
CTTGGCAATGATATCTG-30) or MS2-CP Fwd (50-CA
CCATGGGATCCGCTTCTAACTTTACTCAGTTCGT
TCTC-30)/MS2-CP Rev (50-TATGAGATCTGTAGATG
CCGGAGTTGGC-30) from human U1A or MS2-GFP
expression plasmids, respectively. In short, the U1A or
MS2 expression plasmid was cloned into pcDNA5-
mycHisA (pcDNA, Invitrogen) containing an Internal
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Ribosomal Entry Site-(IRES)-driven DsRed-Express ex-
pression cassette from pIRES2-DsRed-Express (Clontech
Laboratories, Mountain View, CA, USA) to construct the
U1A or MS2 expression plasmid, and the sequence was
veriﬁed.
EGFP expression control of the devices in
cultured cells
The oligo sequences for constructing the shRNA expres-
sion plasmids are shown in (Supplementary Table S1). To
assess the p50-responsive shRNAs (p50- or dp50-sh 22–28),
293FT cells (1.5 105 per well) grown for one day in
24-well plates were co-transfected with 0.3mg of one of
the following: p50- or dp50-sh 22–28 expression plasmid,
0.3 mg p50 orMS2 expression plasmid and EnhancedGreen
Fluorescent Protein (EGFP) expression plasmid using 2 ml
of Lipofectamine 2000 (Invitrogen). To assess the
U1A-responsive shRNAs, we used the corresponding
shRNA-expressing plasmid instead of p50-sh 22–28.
Twenty-four hours after transfection, following ﬂuorescent
microscopic analysis, the cells were collected and resus-
pended in the medium, and the mean intensity of EGFP
ﬂuorescence was determined using a ﬂow cytometer
(FACSAria, BD Bioscience). To exclude abnormal cells,
those cells whose Foward Scatter and Side Scatter signal
scopes were identical to those of untreated 293FT cells were
selected for the calculation of mean intensities, and 30 000
cells per each sample were analysed. To measure the EGFP
signal, a 488-nm semiconductor laser beam and a 530/30-
nm emission detector were used.
RESULTS
Design principle of protein-responsive shRNA devices
We chose to design shRNA structures because they
contain a simple stem-loop structure and have been used
as powerful tools to knock down desired genes through
the RNAi pathway. Human Dicer recognizes shRNA at
the end of its stem and cleaves it at approximately the
22nd nucleotide from the 30 and/or 50 end to produce a
functional dsRNA for performing RNAi (24,25). Human
Dicer does not discriminate according to the size and
structure of the shRNA loop region during its processing;
therefore, desired sequences can generally be incorporated
into the loop region (26). We have previously constructed
a synthetic shRNA by simply inserting a kink-turn RNA
motif (Kt), which binds to the ribosomal protein L7Ae in
Archaeoglobus fulgidus (2), into the shRNA loop region.
L7Ae modulates the function of Dicer through its speciﬁc
binding to the shRNA; however, it is unclear whether the
protein-binding site is optimally set in the shRNA to
maximize the steric hindrance to obstruct Dicer. To
solve this problem, we took a 3D molecular design
approach to constructing sophisticated protein-responsive
shRNA devices. The ability of the RNA-binding protein
to inhibit Dicer-mediated cleavage should directly deter-
mine the RNA device’s efﬁciency of RNAi control because
steric hindrance can be predicted from the 3D model of
Dicer and the shRNA–protein complexes (schematic rep-
resentation and corresponding 3D structure are shown in
Figure 1A). Accordingly, the engineered shRNA with a
speciﬁc protein-binding site was designed by adding bp
between the double-stranded region and the loop to
adjust the orientation and distance from the Dicer
cleavage site (Figure 1B).
In the 3D model, we predicted the region that is
required by human Dicer to cleave the shRNA based on
the high-resolution X-ray structure of Giardia Dicer and a
single-particle analysis of human Dicer using electron mi-
croscopy (27,28). Although the entire crystal structure of
human Dicer has not been solved, previous structural
studies have revealed that the regions responsible for
nuclease activity of both human and Giardia Dicers are
similar (27,29). Two structural models of human Dicer
have been proposed by incorporating the Giardia Dicer
crystal structure into the human Dicer electron micros-
copy map (27). A credible model from previous structural
and biochemical studies indicates that a helicase domain is
located adjacent to the RNaseIII domains (26,27).
However, it has been reported that the disruption of the
helicase domain maintains the stability and activity of
human Dicer (30–32), indicating that the activity of
human Dicer is not affected. Therefore, we did not
account for the helicase domain in our 3D model.
3D molecular design of U1A-responsive shRNA devices
We designed a series of shRNA devices that respond to the
expression of U1A (referred to as U1A1-sh 21–31; Figure
2). U1A is one of the most abundantly expressed
mRNA-processing and housekeeping proteins in mamma-
lian cells (33).We used theU1AN-terminal domain (amino
acids 2–98), which does not contain the region for nuclear
localization signal (amino acids 100–144), indicating that
the expressed U1A will be present in both the cytoplasm
and nucleus. The U1A1-sh 21–31 RNAs consist of a loop
region containing an RNA motif for binding to U1A and
21–31 consecutive bp containing the target sequence for an
mRNA-encoding EGFP (Supplementary Figure S1A). The
engineered shRNAs were designed based on a speciﬁc RNP
complex, which is U1A’s N-terminal domain that is
associated with the corresponding U1A-binding motif in
human U1’s small nuclear RNA stem-loop II, whose
high-resolution 3D structure is known (34,35). We used
a 3D modeling method to deﬁne the degree of steric
hindrance between human Dicer and U1A to optimize
the performance of the device (+U1A, Figure 2,
SupplementaryMovies S1 and S2). Thus, if U1A interfered
with the region that is required for the Dicer’s recognition,
it is likely to cause inhibition of the Dicer function. Indeed,
the steric hindrance between the Dicer and U1A (with
U1A1-sh 23–29) was observed, and then, the RNP
complex of U1A1-sh 30–31 exceeded the expected access
region of Dicer in our in silico 3D modeling (Figure 2,
Supplementary Movie S2).
Biochemical and in cell analyses of U1A-responsive
shRNA devices
To conﬁrm the prediction that was derived from the 3D
modeling of the U1A1-shRNA device, we investigated
whether the in vitro-transcribed U1A1-sh 21–31 and the
Nucleic Acids Research, 2012, Vol. 40, No. 18 9371










corresponding negative control, dU1A1-sh 21–31, which
contained a defective U1A binding motif (Supplementary
Figure S1B), are processed by recombinant human Dicer
in the presence or absence of U1A protein (Figure 3A and
B and Supplementary Figure S2). In the absence of U1A,
Dicer cleaved the transcribed U1A1-sh 21–31 in vitro,
which indicated that human Dicer can recognize and
cleave the designed shRNAs containing the U1A-binding
motif at the loop region (Figure 3A). As expected, the
predicted effect of steric hindrance corresponded to the
Figure 1. Schematic and structural model of the protein-responsive shRNA device mechanism and its bound protein orientation. (A) In the absence
of the RNA-binding protein, the shRNA-processing enzyme Dicer (grey) can access and process the designed shRNA, and the processed shRNA
induces the knockdown of its target gene through an RNAi mechanism (left). In contrast, Dicer is inaccessible to shRNA in the presence of a protein
(pink) that binds to the loop region of the shRNA (yellow) because the RNP interaction faces Dicer and inhibits its access. The prevention of Dicer’s
function causes the derepression of the gene knockdown (right). (B) Protein-responsive shRNA devices A and B are designed by connecting an
RNA–protein interaction motif with each length (A: 24 bp, B: 21 bp) of dsRNA. By specifying the position of two devices by reference to Dicer
cleavage sites and comparing these two bound proteins’ locations, we found that the protein bound on device A is located 7.8 A˚ more distant to the
Dicer cleavage sites and rotates 90 in an anti-clockwise direction around the axis of the dsRNA compared with that bound on device B. Dicer
cleavage sites are shown in two ﬁlled red and blue circles.
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degree of inhibition of the Dicer function in the presence
of U1A (Figure 3A and B and Supplementary Figure
S2B). Importantly, the U1A1-sh 30–31 less efﬁciently in-
hibited Dicer cleavage when compared with U1A1-sh
24–29, indicating that the longer stem in U1A1-sh 30–31
can release the U1A-mediated inhibition of Dicer activity
(Figure 3A and B). As anticipated, the result is consistent
with the prediction based on the in silico models (Figure 2,
sh30–31). We next investigated the cellular function of
U1A1-sh 21–25 because the inhibition efﬁciency of Dicer
cleavage observed for U1A1-sh 26–29 stays roughly
constant. The designed U1A1-sh 21–25 expression
plasmids or the corresponding negative control dU1A1-
sh 21–25 expression plasmids were transfected into
human cultured 293FT cells expressing U1A or the
control bacteriophage MS2 coat protein. Twenty-four
hours after transfection, the level of EGFP was
measured with a ﬂow cytometer. In the MS2-expressing
cells, efﬁcient down-regulation of EGFP expression was
observed when U1A1-sh 22–25 was transfected (red bars,
Figure 3C). RNAi activity of U1A1-sh 21 and dU1A1-sh
21 was weaker than that of the other constructs (sh 22–25)
(Figure 3C), indicating that the 21-bp length of the
double-stranded region of the shRNAs is likely incompe-
tent for Dicer processing in cell. The effective
de-repression of EGFP expression when U1A1-sh 25
was transfected into U1A-expressing cells was observed
by ﬂow cytometry (blue bars, Figure 3C and
Supplementary Figure S3) and ﬂuorescent microscopy
(Figure 3D). The binding-defective shRNA expression
plasmids (dU1A1-sh 22–25) had no inﬂuence on RNAi
activity in vitro Dicer cleavage assay (Supplementary
Figure S2) and in cells expressing U1A (Figure 3C
and Supplementary Figure S3), indicating that the
Figure 2. Predicted steric hindrance of U1A with Dicer in the 3D model of U1A-responsive shRNA devices. A 3D model of the catalytic domain
and peripheral structure of Giardia Dicer (PDB ID: 2QVW, 326-385, 401- C-terminal amino acids), which is analogous to that of human Dicer,
(white and white translucent) is displayed. Eleven U1A protein-responsive shRNA device variants, U1A1-sh 21–31 (white ribbon) and bound U1A
(orange) are shown. U1A1-sh 21–31 consists of a loop region (green) that contains a U1A-binding motif with 21–31 bp of dsRNA targeting the
EGFP gene. These models were arrayed with reference to the dsRNA axis and by producing two nucleotides (red spheres: 22nd nucleotide from the
50 end and blue spheres: 22nd nucleotide from the 30 end) that are located between the two metal ions of catalytic sites of Giardia Dicer. The expected
accessing region of Dicer was indicated by a white translucent area.
Nucleic Acids Research, 2012, Vol. 40, No. 18 9373










RNA–protein interaction is responsible for suppressing
RNAi activity. Thus, it is conceivable that the degree of
steric hindrance between U1A and human Dicer is pre-
dictable from the 3D models. U1A located on the U1A1-
sh 25 effectively interfered with the Dicer accessible region
(Figure 2 and Supplementary Movie S2). The effect of this
steric hindrance observed in U1A1-sh23–25-U1A complex
models was positively correlated with the ability to
de-repress EGFP expression in a phased manner
(Figures 2 and 3 and Supplementary Figure S3).
3D molecular design and in cell analyses of p50-responsive
shRNA devices
To conﬁrm the versatility of the molecular design based on
the 3D structure, we constructed a series of shRNA
Figure 3. In vitro and cellular performance of U1A-responsive shRNA devices. (A) Human Dicer cleavage assay in vitro. U1A1-sh 21–31 and U1A
formed the RNP complex. U1A1-sh 23–29 modulated Dicer activity in the presence of U1A. (B) The relative efﬁciency values of Dicer cleavage
observed in (A) were calculated using the ratio of the cleaved band intensity in the presence of U1A to that in the absence of U1A and normalized to
the value of dU1A1-sh 21–31 (see also Supplementary Figure S2). (C) Flow cytometric analysis of the regulation of the RNA device variants by U1A
in 293FT cells. 293FT cells were co-transfected with the three plasmids that expressed U1A or MS2, EGFP and one of the U1A1- or dU1A1-sh
variants and were analysed the next day. The relative expression levels of EGFP ﬂuorescence in the U1A- or MS2-expressing cells were normalized to
the EGFP expression levels of the sh-N (negative control for EGFP knockdown, see Supplementary Table S1) and U1A- or MS2-expressing cells.
The error bars indicate the standard deviations of three independent experiments. sh-GFP was used as a positive control for EGFP knockdown. (D)
Fluorescent microscopic images of cells that expressed EGFP, U1A1- or dU1A1-sh 25 and U1A or MS2 from each plasmid.
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devices that respond to the p50 domain of NF-kB (Figure
4A and Supplementary Movies S3 and S4). NF-kB is one
of the major transcription factors in eukaryotic cells, and
its abnormal expression has been linked to the prolifer-
ation of several types of tumor cells (36,37). The
NF-kB-responsive shRNAs (referred to as p50-sh 22–28)
consist of a loop region containing a speciﬁc binding site
for p50 and a stem (22–28 bp), which contains the target-
ing sequence for an mRNA-coding EGFP (Figure 4A and
Supplementary Figure S4A). The p50 domain consists of
two parts: the N-terminal domain (p50-N, colored sky
blue) and the C-terminal domain (p50-C, colored green;
p50-N and p50-C are connected via a linker peptide in
Figure 4A). The p50-N, but not the p50-C, domain
tightly binds to the aptamer sequence inserted into the
loop region of the shRNA (Figure 4A) (38,39). Notably,
p50 does not contain a nuclear localization signal peptide;
therefore, the expressed p50 will be present in the both the
cytoplasm and nucleus.
The properties of the designed p50-sh 22–28 expres-
sion plasmids and the corresponding negative control
dp50-sh 22–28 expression plasmids containing a defective
p50 aptamer (Supplementary Figure S4B) were examined
in 293FT cells that expressed p50 or MS2. In the
MS2-expressing cells, a pronounced and moderate
down-regulation of EGFP expression was observed
when p50-sh 22–26 and p50-sh 27–28 expression
plasmids were transfected, respectively (Figure 4B).
In vitro-transcribed p50-sh 22–28 RNAs are processed
by recombinant human Dicer in a similar manner
(Supplementary Figure S5A and S5B). In the presence of
p50, the down-regulation of EGFP was suppressed
when p50-sh 26–28 expression plasmids were transfected
(Figure 4B and C and Supplementary Figure S5C). The
defective shRNAs (dp50-sh 22–28) that were incapable of
binding to p50 had no inﬂuence on RNAi activity in cells
expressing p50 (Figure 4B & Supplementary Figure S5C).
It is conceivable that the degree of the steric hindrance
between p50 and Dicer is predictable from the 3D
models as in the case of U1A; p50 that is located on sh
26–28 effectively interferes with the Dicer accessible region
(+p50, Figure 4A and Supplementary Movie S4).
3D design and cellular function of an alternative device
with the protein-stabilized RNA structural motif
As an extension of this design, we constructed an alterna-
tive device with a more complex 3D RNP structure
(Supplementary Figure S6). We attempted to inhibit
Dicer function by using both an RNA-binding protein
and the protein-stabilized RNA structural motif because
Figure 4. Prediction and assessment of the steric hindrance between Dicer and NF-kB p50 attached to p50-responsive shRNA devices. (A) The 3D
model of seven p50 protein-responsive shRNA device variants, p50-sh 22–28 (white ribbon) and bound p50 (N-terminal domain with linker: sky blue;
C-terminal domain: dark green). p50-sh 22–28 consists of the loop region (yellow) that contains an aptamer for p50 with 22–28 bp of dsRNA. These
models were arrayed using the same procedure as shown in Figure 2. (B) Flow cytometric analysis of the regulation of the p50-sh variants by p50
expression in 293FT cells. 293FT cells were co-transfected with the three plasmids that expressed p50 or MS2, EGFP and one of the p50- or dp50-sh
variants and were analysed the next day. The relative expression levels of EGFP ﬂuorescence in the p50- or MS2-expressing cells were normalized to
the EGFP expression levels of the sh-N and p50 or MS2 expressing cells. The error bars indicate the standard deviations of three independent
experiments. sh-GFP was used as the positive control for EGFP knockdown. (C) Fluorescent microscopic images of cells that expressed EGFP,
p50- or dp50-sh 27, and p50 or MS2 from each plasmid.
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a certain RNA–protein interaction is known to stabilize
the RNA structural motif containing the protein-binding
site (40). Accordingly, we incorporated the U1A-binding
RNA motif into the loop region that is ﬂanked by the two
RNA stems; the U1A-stabilized RNA structural motif
presumably contributes to the effect of steric hindrance.
The corresponding construct (U1A2-sh 21–27) was
designed to exhibit a loop-stem-loop structure (shown in
green) and contains the U1A-binding motif that is con-
nected to the main stem (21–27 bp; Supplementary Figure
S6A) (33,40). The loop-stem-loop motif of U1A2-sh is pre-
dicted to be more rigid than the loop structure of U1A1-sh
in terms of RNA secondary structure (40). The 3D model
of the shRNA–U1A complex shows that the protruding
portion of the RNA UUCG loop with the 50-GUCC/
GGAC-30 stem region (which is referred to as the
UUCG stem-loop) and U1A are arranged symmetrically
(Supplementary Figure S6B). The steric hindrance
between Dicer and U1A (U1A2-sh 21 and U1A2-sh
24–27) or between Dicer and the UUCG stem-loop that
is bound to U1A (U1A2-sh 21–24) can be seen in the 3D
models.
To test the cellular function of the U1A2-sh 21–27 RNA
devices, we transfected the designed expression plasmids
(U1A2-sh 21–27 and dU1A2-sh21–27; Supplementary
Figure S6A) into 293FT cells that expressed either U1A
or control MS2 (Supplementary Figure S7). The
suppression of RNAi was observed when the U1A2-sh
22–26 constructs were transfected into the
U1A-expressing cells. We conﬁrmed that the designed
U1A2-sh 24 interacted speciﬁcally with recombinant
U1A and that the catalytic activity of Dicer was efﬁciently
blocked by the RNP interaction in vitro (Supplementary
Figure S8). U1A presumably stabilizes the conformation
of the UUCG stem-loop region so that both the
U1A-stabilized UUCG stem-loop region and U1A
should become responsible for steric hindrance with
Dicer (Supplementary Figure S6). Both U1A2-sh 21 and
U1A2-sh 27 and their negative control plasmids induce
RNAi weakly in the absence of U1A when compared
with U1A2-sh 22–26 and their negative control plasmids,
indicating that the performance of the designed switches
reﬂect a balance between the proper positioning of the
U1A–shRNA complex to interfere with Dicer and the
activity of the designed shRNA (without protein) to
proceed in the correct RNAi pathway. In particular,
both U1A2-sh 27 and p50-sh 27–28 (and their negative
control plasmids) with longer dsRNA region induce
RNAi weakly in the absence of the corresponding
protein compared with the other constructs with shorter
dsRNA regions (Figure 4B and Supplementary Figure
S7A). Thus, longer dsRNA region (>27 bp) of the
shRNA seems incompetent for facilitating cellular RNAi
pathway. Consequently, synthetic shRNAs with the
proper lengths of dsRNA (22–27 bp) should be used for
building a more diverse array of orthogonal devices: the
range from 22 to 27 bp dsRNA is likely sufﬁcient to
generate the optimal shRNA devices. The 22–27
shRNAs can rotate the RNA motif 150 (Figures 2
and 4A) so that the steric hindrance can be optimized
within the range in most cases.
DISCUSSION
We have demonstrated that the 3D modeling of synthetic
shRNAs and RNA-binding proteins is highly useful for
developing efﬁcient and tunable protein-responsive RNA
devices; in silico 3D modeling predicted functional devices
that control RNAi in mammalian cells. The designed
protein-responsive shRNAs provide the proper orienta-
tion of the bound protein on the structured RNA loop
for disturbing Dicer-dependent RNA cleavage activity in
the 3D model.
For our 3D model of human Dicer, we referred to
RNaseIII’s catalytic domain and the peripheral structure
of Giardia Dicer because structural studies have indicated
that the crystal structure of Giardia Dicer is geometrically
similar to the nuclease core of human Dicer (27,29). For
our in silico 3D modeling, in vitro Dicer cleavage and
cellular gene expression analyses indicated that there is a
clear correlation between the model and our experimental
data: The designed RNA devices can efﬁciently regulate
the function of Dicer in human cells as in the case of the
in vitro experiments, although we are unable to disregard
the possibility that unexpected interactions between the
RNP and some other molecules might affect the regula-
tion of the shRNA devices in cells.
The introduction of a set of RNA devices that respond
to multiple proteins could simultaneously and inde-
pendently control multiple signals to improve the per-
formance of synthetic signaling circuits in a single cell.
For example, we have succeeded in re-directing apoptosis
pathways of cultured human cells by using two distinct
RNA devices that simultaneously regulate the expression
of two apoptosis regulatory proteins (2). In addition, the
RNA devices responding to endogenously produced
proteins could rewire gene regulatory networks for thera-
peutic applications. For example, the in vivo systemic
delivery systems of shRNA have been developed,
although the precise delivery to the speciﬁc cells of
interest remains unresolved (41). Our protein-responsive
shRNA devices could be advantageous for controlling
RNAi activity in the target cells because the function of
synthetic shRNAs can be regulated depending on intracel-
lular environment.
Precisely and strictly controllable RNA devices could be
designed and developed based on the 3D structure by:
(i) introducing multiple RNP interaction motifs into the
appropriate region(s) of the shRNA device, (ii) altering
the binding afﬁnity and speciﬁcity to the sensing protein
of interest or (iii) regulating the degree of steric hindrance
between RNA and the corresponding RNA-binding
proteins. Therefore, the 3D design of synthetic RNP-
mediated information converters could contribute to the
synthetic biology and other ﬁelds as a versatile tool for
biomacromolecular design (9,16,17). This design principle
can be applied to other biomacromolecular complexes
(e.g. DNA–protein or protein–protein complexes) whose
high-resolution 3D structures have already been solved. In
addition, the 3D design strategies that are used to inves-
tigate the effects of steric hindrance between RNA and
proteins on the function of RNA-processing enzymes
could be useful for studying the relationship between the
9376 Nucleic Acids Research, 2012, Vol. 40, No. 18










molecular mechanisms and the structures of naturally
occurring RNP complexes that are involved in RNA pro-
cessing and/or regulation pathways (22,27).
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